Haicheung the shareholders of the pharmaceutical tycoon

If the controlling shareholder of a listed company keeps reducing, it will be seen as a signal of "bad outlook" for the investors, and if a company has an equity incentive scheme for senior executives, it is often seen as a good result of "executives being locked in performance and stock prices". Such contradictory signals are now present at the same time in the Hai Xiang Pharmaceutical Industry (002099).　　SZ). Haicheung pharmaceutical Industry Today, September 7, 8th, the major shareholder Robonpeng two times through the bulk trading system to reduce 1 million shares and 1.121 million shares, selling prices for each share of 22.38 yuan, 22.08 yuan. The total number of shares reduced to 1.32% of the total share capital of the Hai Xiang Pharmaceutical industry in two days. In fact, this is not the first time Robonpeng to reduce the shares of the sea Xiang pharmaceutical industry. Robonpeng and its concerted action person Zhengzhiguo has repeatedly reduced the shares of the sea Xiang pharmaceutical industry. The earliest a reduction occurred in this January 29, the same day Zhengzhiguo reduce 1.346 million shares, Robonpeng reduce 1.6 million shares. Since then, along with the share price rose, this year February 1, April 21, June 9, August 31, Robonpeng has been gradually reducing the shares of the sea Xiang pharmaceutical industry. By August 31 this year, Robonpeng and Zhengzhiguo also issued the report on the change of equity due to the total number of shares to reach the total capital of Hai Xiang Pharmaceutical industry 5%.　　According to regulations, Robonpeng and Zhengzhiguo in the six months after September 1, the number of shares should not exceed the total share of the sea Xiang pharmaceutical 5%. June 29 This year, the Hai Xiang Pharmaceutical company issued an incentive scheme for equity, the executive and the backbone of the staff to carry out equity incentives. In August this year, 73 executives and the backbone of the company have issued a first-stage incentive shares. The right to motivate shares of 10.71 Yuan, yesterday close, Hai Xiang Pharmaceutical stock has reached 25.2 yuan.